Currently, no variant exhibits a significant growth advantage, in contrast to November 2023, when the dominant JN.1 variant surfaced.

Estimated relative growth advantage of main variants in the UK for Apr 2024 and Nov 2023

(Please use a modern browser to see the interactive version of this visualization)

Note that the chart only shows the variants with the three highest positive relative growth advantage

Chart: Bob HawkinsSource: UKHSAGet the dataCreated with Datawrapper